Cargando…

TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization

Background: Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from Tc infection in mice and dogs. Trypanosoma rangeli (Tr) is non-pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Shivali, Salgado-Jiménez, Berenice, Lokugamage, Nandadeva, Vázquez-Chagoyán, Juan Carlos, Garg, Nisha Jain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606718/
https://www.ncbi.nlm.nih.gov/pubmed/31293599
http://dx.doi.org/10.3389/fimmu.2019.01456
_version_ 1783431952874864640
author Gupta, Shivali
Salgado-Jiménez, Berenice
Lokugamage, Nandadeva
Vázquez-Chagoyán, Juan Carlos
Garg, Nisha Jain
author_facet Gupta, Shivali
Salgado-Jiménez, Berenice
Lokugamage, Nandadeva
Vázquez-Chagoyán, Juan Carlos
Garg, Nisha Jain
author_sort Gupta, Shivali
collection PubMed
description Background: Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from Tc infection in mice and dogs. Trypanosoma rangeli (Tr) is non-pathogenic to mammals and shown to elicit cross-reactive anti-Tc antibodies. In this study, we investigated if fixed Tr (fTr) can further enhance the efficacy of the TcG2/TcG4 DNA vaccine. Methods and Results: C57BL/6 mice were immunized with TcG2/TcG4 DNA vaccine and fTr (delivered as an adjuvant or in prime-boost approach), and challenged with Tc. Serology studies showed that fTr (±quil-A) elicited Tc- and Tr-reactive IgGs that otherwise were not stimulated by TcG2/TcG4 vaccine only, and quil-A had suppressive effects on fTr-induced IgGs. After challenge infection, TcG2/TcG4-vaccinated mice exhibited potent expansion of antigen- and Tc-specific IgGs that were not boosted by fTr±quil-A. Flow cytometry analysis showed that TcG2/TcG4-induced dendritic cells (DC) and macrophages (Mφ) responded to challenge infection by expression of markers of antigen uptake, processing, and presentation, and production of pro-inflammatory cytokines. TcG2/TcG4-induced CD4(+)T cells acquired Th1 phenotype and expressed markers that orchestrate adaptive immunity. A fraction of vaccine-induced CD4(+)T cells exhibited iTreg phenotype responsible for aversion of self-injurious immune responses. Further, TcG2/TcG4-vaccinated mice exhibited potent expansion of poly-functional CD8(+)T cells with TNF-α/IFN-γ production and cytolytic phenotype post-infection. Subsequently, tissue parasites and pathology were hardly detectable in TcG2/TcG4-vaccinated/infected mice. Inclusion of fTr±quil-A had no clear additive effects in improving the Tc-specific adaptive immunity and parasite control than was noted in mice vaccinated with TcG2/TcG4 alone. Non-vaccinated mice lacked sufficient activation of Th1 CD4(+)/CD8(+)T cells, and exhibited >10-fold higher levels of tissue parasite burden than was noted in vaccinated/infected mice. Conclusion: TcG2/TcG4 vaccine elicits highly effective immunity, and inclusion of fTr is not required to improve the efficacy of DNA vaccine against acute Tc infection in mice.
format Online
Article
Text
id pubmed-6606718
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66067182019-07-10 TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization Gupta, Shivali Salgado-Jiménez, Berenice Lokugamage, Nandadeva Vázquez-Chagoyán, Juan Carlos Garg, Nisha Jain Front Immunol Immunology Background: Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from Tc infection in mice and dogs. Trypanosoma rangeli (Tr) is non-pathogenic to mammals and shown to elicit cross-reactive anti-Tc antibodies. In this study, we investigated if fixed Tr (fTr) can further enhance the efficacy of the TcG2/TcG4 DNA vaccine. Methods and Results: C57BL/6 mice were immunized with TcG2/TcG4 DNA vaccine and fTr (delivered as an adjuvant or in prime-boost approach), and challenged with Tc. Serology studies showed that fTr (±quil-A) elicited Tc- and Tr-reactive IgGs that otherwise were not stimulated by TcG2/TcG4 vaccine only, and quil-A had suppressive effects on fTr-induced IgGs. After challenge infection, TcG2/TcG4-vaccinated mice exhibited potent expansion of antigen- and Tc-specific IgGs that were not boosted by fTr±quil-A. Flow cytometry analysis showed that TcG2/TcG4-induced dendritic cells (DC) and macrophages (Mφ) responded to challenge infection by expression of markers of antigen uptake, processing, and presentation, and production of pro-inflammatory cytokines. TcG2/TcG4-induced CD4(+)T cells acquired Th1 phenotype and expressed markers that orchestrate adaptive immunity. A fraction of vaccine-induced CD4(+)T cells exhibited iTreg phenotype responsible for aversion of self-injurious immune responses. Further, TcG2/TcG4-vaccinated mice exhibited potent expansion of poly-functional CD8(+)T cells with TNF-α/IFN-γ production and cytolytic phenotype post-infection. Subsequently, tissue parasites and pathology were hardly detectable in TcG2/TcG4-vaccinated/infected mice. Inclusion of fTr±quil-A had no clear additive effects in improving the Tc-specific adaptive immunity and parasite control than was noted in mice vaccinated with TcG2/TcG4 alone. Non-vaccinated mice lacked sufficient activation of Th1 CD4(+)/CD8(+)T cells, and exhibited >10-fold higher levels of tissue parasite burden than was noted in vaccinated/infected mice. Conclusion: TcG2/TcG4 vaccine elicits highly effective immunity, and inclusion of fTr is not required to improve the efficacy of DNA vaccine against acute Tc infection in mice. Frontiers Media S.A. 2019-06-26 /pmc/articles/PMC6606718/ /pubmed/31293599 http://dx.doi.org/10.3389/fimmu.2019.01456 Text en Copyright © 2019 Gupta, Salgado-Jiménez, Lokugamage, Vázquez-Chagoyán and Garg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Gupta, Shivali
Salgado-Jiménez, Berenice
Lokugamage, Nandadeva
Vázquez-Chagoyán, Juan Carlos
Garg, Nisha Jain
TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title_full TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title_fullStr TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title_full_unstemmed TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title_short TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
title_sort tcg2/tcg4 dna vaccine induces th1 immunity against acute trypanosoma cruzi infection: adjuvant and antigenic effects of heterologous t. rangeli booster immunization
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606718/
https://www.ncbi.nlm.nih.gov/pubmed/31293599
http://dx.doi.org/10.3389/fimmu.2019.01456
work_keys_str_mv AT guptashivali tcg2tcg4dnavaccineinducesth1immunityagainstacutetrypanosomacruziinfectionadjuvantandantigeniceffectsofheterologoustrangeliboosterimmunization
AT salgadojimenezberenice tcg2tcg4dnavaccineinducesth1immunityagainstacutetrypanosomacruziinfectionadjuvantandantigeniceffectsofheterologoustrangeliboosterimmunization
AT lokugamagenandadeva tcg2tcg4dnavaccineinducesth1immunityagainstacutetrypanosomacruziinfectionadjuvantandantigeniceffectsofheterologoustrangeliboosterimmunization
AT vazquezchagoyanjuancarlos tcg2tcg4dnavaccineinducesth1immunityagainstacutetrypanosomacruziinfectionadjuvantandantigeniceffectsofheterologoustrangeliboosterimmunization
AT gargnishajain tcg2tcg4dnavaccineinducesth1immunityagainstacutetrypanosomacruziinfectionadjuvantandantigeniceffectsofheterologoustrangeliboosterimmunization